2021
DOI: 10.1002/psp4.12715
|View full text |Cite
|
Sign up to set email alerts
|

Heterogeneous treatment effect analysis based on machine‐learning methodology

Abstract: Heterogeneous treatment effect (HTE) analysis focuses on examining varying treatment effects for individuals or subgroups in a population. For example, an HTE‐informed understanding can critically guide physicians to individualize the medical treatment for a certain disease. However, HTE analysis has not been widely recognized and used, even given the explosive increase of data availability attributed to the arrival of the Big Data era. Part of the reason behind its underuse is that data are often of high dime… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
20
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 24 publications
(20 citation statements)
references
References 38 publications
0
20
0
Order By: Relevance
“…From a regulatory perspective, AI/ML approaches can be leveraged across several areas to support overall drug development and regulatory efficiency. This includes, but is not limited to: causal inference 47 ; automation tools for bioequivalence assessment 48 or facilitating product specific guidance 49 ; business intelligence to predict submissions of abbreviated new drug applications 50,51 ; regulatory equivalence assessment for complex particle size distribution 52 ; and multivariate analysis methods to facilitate active pharmaceutical ingredient sameness assessment. 53 Of note, the value of adopting AI/ML approaches to mine large and heterogenous datasets has been shown in recent regulatory applications focusing on the assessment of heterogeneous treatment effect (HTE).…”
Section: Ai/ml-enabled Regulatory Assessmentmentioning
confidence: 99%
“…From a regulatory perspective, AI/ML approaches can be leveraged across several areas to support overall drug development and regulatory efficiency. This includes, but is not limited to: causal inference 47 ; automation tools for bioequivalence assessment 48 or facilitating product specific guidance 49 ; business intelligence to predict submissions of abbreviated new drug applications 50,51 ; regulatory equivalence assessment for complex particle size distribution 52 ; and multivariate analysis methods to facilitate active pharmaceutical ingredient sameness assessment. 53 Of note, the value of adopting AI/ML approaches to mine large and heterogenous datasets has been shown in recent regulatory applications focusing on the assessment of heterogeneous treatment effect (HTE).…”
Section: Ai/ml-enabled Regulatory Assessmentmentioning
confidence: 99%
“…The heterogeneity further detected in CF model is also quite critical, which focuses on evaluating the different causal effects across individuals or subgroups. With the heterogeneous analysis, doctors could be guided to conduct personalized treatments for speci c diseases [37]. Moreover, the heterogeneity is speci c helpful when evaluating the effect of public policy.…”
Section: Causal Inferencementioning
confidence: 99%
“…However, this is challenging because real‐world data are complex, noisy, and highly dimensional. Recent studies on HTE have proposed machine learning (ML) methods due to their superior performance on increasingly complex and high‐dimensional data 11 . One common approach is to apply the ML method to build models for the control group μ0false(xifalse)$$ {\mu}_0\left({\boldsymbol{x}}_i\right) $$ and treatment group μ1(xi)$$ {\mu}_1\left({\boldsymbol{x}}_i\right) $$, and using the estimates of each group to calculate the HTE 12 .…”
Section: Introductionmentioning
confidence: 99%
“…Recent studies on HTE have proposed machine learning (ML) methods due to their superior performance on increasingly complex and high-dimensional data. 11 One common approach is to apply the ML method to build models for the control group 𝜇 0 (x i ) and treatment group 𝜇 1 (x i ), and using the estimates of each group to calculate the HTE. 12 However, these models can have different structures (ie, the basis function).…”
mentioning
confidence: 99%